Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Editorial

Published on 05 Apr 2024

Editorial: Overcoming obstacles of cancer immunotherapy: the important role of emerging nanomedicine

in Pharmacology of Anti-Cancer Drugs

Aimin Jiang
Wangxiao He
Yu Yao

Frontiers in Oncology

doi 10.3389/fonc.2024.1406244

1,068 views
1 citation

Editorial

Published on 04 Apr 2024

Editorial: Advances in molecular and pharmacological mechanisms of novel targeted therapies for melanoma

in Pharmacology of Anti-Cancer Drugs

Marcel Henrique Marcondes Sari
Luana Mota Ferreira

Frontiers in Oncology

doi 10.3389/fonc.2024.1403778

657 views

Review

Published on 25 Mar 2024

Research progress on the antitumor effects of harmine

in Pharmacology of Anti-Cancer Drugs

Yonghua Hu
Xiaoli Yu
Lei Yang
Gaimei Xue
Qinglin Wei
Zhijian Han
Hao Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1382142

3,594 views
6 citations

Original Research

Published on 21 Mar 2024

Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposure

in Pharmacology of Anti-Cancer Drugs

Anna Spreafico
Eva Muñoz Couselo
Anja Irmisch
Juliana Bessa
George Au-Yeung
Oliver Bechter
Inge Marie Svane
Miguel F. Sanmamed
Valentina Gambardella
Meredith McKean

Frontiers in Oncology

doi 10.3389/fonc.2024.1346502

5,717 views
3 citations

Original Research

Published on 20 Mar 2024

Pyroptosis-related gene signature for predicting gastric cancer prognosis

in Pharmacology of Anti-Cancer Drugs

Salem Saeed Saad Khamis
Jianhua Lu
Yongdong Yi
Shangrui Rao
Weijian Sun

Frontiers in Oncology

doi 10.3389/fonc.2024.1336734

1,784 views
1 citation

Case Report

Published on 07 Mar 2024

Immune checkpoint inhibitor-related acquired amegakaryocytosis thrombocytopenia: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Valérian Rivet
Vincent Sibaud
Jérémie Dion
Thibaut Volosov
Mélanie Biteau
Andréa Pastissier
Karen Delavigne
Pierre Cougoul
Odile Rauzy
Thibault Comont

Frontiers in Oncology

doi 10.3389/fonc.2024.1353896

1,896 views
1 citation

Original Research

Published on 07 Mar 2024

Photodynamic therapy with paclitaxel-encapsulated indocyanine green-modified liposomes for breast cancer

in Pharmacology of Anti-Cancer Drugs

Mariko Ishizuka
Masaki Kaibori
Fusao Sumiyama
Yoshiharu Okamoto
Akiko Suganami
Yutaka Tamura
Kengo Yoshii
Tomoharu Sugie
Mitsugu Sekimoto

Frontiers in Oncology

doi 10.3389/fonc.2024.1365305

3,086 views
2 citations

Original Research

Published on 26 Feb 2024

Localized radiotherapy of solid tumors using radiopharmaceutical loaded implantable system: insights from a mathematical model

in Pharmacology of Anti-Cancer Drugs

Anahita Piranfar
Mohammad Souri
Arman Rahmim
Madjid Soltani

Frontiers in Oncology

doi 10.3389/fonc.2024.1320371

2,062 views
16 citations

Original Research

Published on 26 Feb 2024

The patient perspective on sirolimus for epithelioid hemangioendothelioma (EHE): results of a community survey highlighting the importance of equitable access to treatments

in Pharmacology of Anti-Cancer Drugs

Denise Robinson
Hugh Leonard
Giacomo Giulio Baldi
William D. Tap
Robin L. Jones
Silvia Stacchiotti
Pan Pantziarka

Frontiers in Oncology

doi 10.3389/fonc.2024.1367237

2,639 views
2 citations

Original Research

Published on 22 Feb 2024

Identification and validation of a gap junction protein related signature for predicting the prognosis of renal clear cell carcinoma

in Pharmacology of Anti-Cancer Drugs

Yongsheng Huang
Wenyi Guo
Yuan Zeng
Xinrong Wang
Bohao Fan
Ying Zhang
Lei Yan
Gangli Gu
Zhao Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1354049

2,701 views

Case Report

Published on 22 Feb 2024

Aplastic anemia secondary to adjuvant Osimertinib therapy: a case report and a review of literature

in Pharmacology of Anti-Cancer Drugs

Ahmed Abdalhadi
Nabil E. Omar
Samah Kohla
Hassan Aakel
Yeslem Ekeibed
Reyad Mohsen

Frontiers in Oncology

doi 10.3389/fonc.2024.1275275

2,244 views
2 citations

Original Research

Published on 22 Feb 2024

The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience

in Pharmacology of Anti-Cancer Drugs

Ningning Yan
Sanxing Guo
Siyuan Huang
Huixian Zhang
Xingya Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1331128

2,999 views

Case Report

Published on 15 Feb 2024

Case report: A rare case of triple negative breast cancer with development of acute pancreatitis due to dexamethasone during adjuvant chemotherapy

in Pharmacology of Anti-Cancer Drugs

Hirofumi Ohmura
Taro Tobo
Yuki Ando
Takaaki Masuda
Koshi Mimori
Koichi Akashi
Eishi Baba

Frontiers in Oncology

doi 10.3389/fonc.2024.1340419

1,962 views
1 citation

Original Research

Published on 15 Feb 2024

Platinum-based neoadjuvant chemotherapy upregulates STING/IFN pathway expression and promotes TILs infiltration in NSCLC

in Pharmacology of Anti-Cancer Drugs

Huan Gao
Xiaoni Zhang
Mengdi Ren
Aimin Jiang
Na Liu
Jingjing Wang
Xiaoqiang Zheng
Xuan Liang
Zhiping Ruan
Tao Tian

Frontiers in Oncology

doi 10.3389/fonc.2024.1346225

1,710 views

Review

Published on 12 Feb 2024

Therapeutic biomarkers in acute myeloid leukemia: functional and genomic approaches

in Pharmacology of Anti-Cancer Drugs

Karanpreet Bhatia
Vedant Sandhu
Mei Hsuan Wong
Prasad Iyer
Shruti Bhatt

Frontiers in Oncology

doi 10.3389/fonc.2024.1275251

4,088 views
6 citations

Brief Research Report

Published on 02 Feb 2024

PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer

in Pharmacology of Anti-Cancer Drugs

Norman Fultang
Ashley M. Schwab
Sophia McAneny-Droz
Alexander Grego
Stephanie Rodgers
Brian Vidal Torres
Diane Heiser
Peggy Scherle
Neha Bhagwat

Frontiers in Oncology

doi 10.3389/fonc.2024.1343004

3,031 views
2 citations